Home › Trials › NCT03848052

Tracking lung cancer treatment evolution in France since 2015

Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015

Observational Unicancer · NCT03848052

This study is collecting and organizing information from lung cancer patients in France to see how their treatments have changed and what outcomes they have experienced since 2015.

Quick facts

Study typeObservational
Enrollment70000 (estimated)
Ages18 Years and up
SexAll
SponsorUnicancer Academic / other
Locations21 sites (Angers and 20 other locations)
Trial IDNCT03848052 on ClinicalTrials.gov

What this trial studies

This observational study compiles data from electronic medical records of lung cancer patients treated at 38 hospitals across France, including comprehensive cancer centers and public hospitals. It focuses on collecting detailed information about patient demographics, tumor characteristics, treatment protocols, and clinical events. Trained technicians gather and harmonize this data using a centralized electronic data collection tool, ensuring that all information is anonymized and aggregated for analysis. The aim is to create a comprehensive database that reflects real-world treatment outcomes and trends in lung cancer care.

Who should consider this trial

Good fit: Ideal candidates for this study are adults over 18 who have been treated for lung cancer or diagnosed with metastatic lung cancer at one of the participating sites.

Not a fit: Patients who have not received treatment for lung cancer or those under 18 may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness of lung cancer treatments and improve patient care strategies.

How similar studies have performed: Other observational studies have successfully utilized real-world data to inform treatment practices, suggesting that this approach is both valid and valuable.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion criteria :

* Adult (over 18)
* Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site

Exclusion criteria

\- None

Where this trial is running

Angers and 20 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Lung Cancerlung cancerobservational studysurvivalreal world datareal life setting
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.